Analyst Ratings for Novus Therapeutics, Inc (NVUS)

NVUS Rating Summary

  |   Expand Research on NVUS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/10/2020 Ladenburg Thalmann N/A New Coverage Buy
(N/A)
43.00
(N/A)
19.79
(14.60)
-26.23% Details
11/27/2019 H.C. Wainwright Vernon Bernardino New Coverage Buy
(N/A)
2.00
(N/A)
0.60
(14.60)
2333.33% Details